Skip to main content

Lymphaticovenous Anastomosis (LVA / LVB)

Lymphaticovenous anastomosis connects a usable lymphatic collector to a nearby vein to bypass impaired drainage. It may reduce swelling, lymphorrhea or cellulitis in selected patients. For genital lymphedema, evidence consists mainly of small uncontrolled series; limb outcomes cannot establish a genital cure rate or show that LVA is safer or more effective than excision or lymph node transfer.[1][2]

See Genital Lymphedema for diagnosis and Complex Decongestive Therapy for conservative care. LVA, vascularized lymph node transfer and excision address different components of disease and may be combined after individual assessment.

Selection and preparation​

Consider specialist lymphatic-surgery assessment for persistent symptoms, recurrent cellulitis or lymphorrhea despite appropriate conservative treatment. The decision depends on the patient's goals, tissue fibrosis, lymphatic anatomy, available venous outflow and ability to continue follow-up. There is no universally validated six-month CDT requirement for genital surgery. Treat active infection and investigate new obstruction or possible cancer recurrence before elective reconstruction.[1][3]

  • A suitable collector and recipient vein are required. Advanced clinical stage or a negative superficial ICG study does not, by itself, prove that every collector is unusable. Ultrasound or other mapping may identify deeper targets. Evidence for this extended selection is mainly from limb cohorts.[4][5]
  • Solid fibrotic enlargement needs separate consideration. LVA does not remove established bulky skin or fibroadipose tissue. Excision and coverage may still be needed for buried penis, severe deformity or disabling tissue bulk.[1][2]
  • Stage alone does not select LVA versus VLNT. The AAPS consensus concerns upper and lower extremities and did not establish which procedure is more effective. A nonfunctional target at one incision is not an automatic indication for lymph node transfer.[3]

Record genital and leg involvement separately, with reproducible measurements or photographs, skin changes, lymph leakage, cellulitis history, compression burden and urinary, sexual and mobility limitations. These provide more useful follow-up than an undefined “success” label.[1][2]

Mapping​

MethodUseful information and limits
ICG lymphographyMaps superficial flow and dermal backflow and can help assess intraoperative flow. Limited penetration and backflow can obscure deeper collectors; limb staging patterns do not automatically define genital surgical eligibility.
Lymphatic ultrasoundComplements ICG by identifying deeper vessels and their wall/lumen characteristics. Operator experience matters; small limb studies do not provide a validated genital detection rate.
MR lymphographyMay help characterize deeper genital collectors, nodes and surrounding tissues. The published Lu selection pathway was one center's small observational experience, not a validated mandatory algorithm.
LymphoscintigraphyAssesses regional transport and drainage patterns but usually lacks the spatial resolution needed to choose each supermicrosurgical target.
Contrast-enhanced ultrasoundAn emerging mapping option at experienced centers. In an 11-woman breast-cancer study, a collector was identified in each patient, but that was not a 100% anastomotic-success rate.

Choose complementary tests according to the clinical question and local expertise. Contrast agent, route and imaging protocol require their own safety review; see ICG.[1][5][6][7][8]

Operative principles​

LVA requires supermicrosurgical training. Local anesthesia and small incisions are feasible for selected superficial procedures; anesthesia, exposure and setting change when genital excision or deeper reconstruction is combined. Published limb techniques commonly use 11-0 or 12-0 nylon. These are descriptions of specialist practice, not a fixed protocol for every genital operation.[9][10][11]

  1. Map the intended drainage territory. Plan incisions where a usable lymphatic and an appropriate vein are accessible. Include the legs or genitalia only when their involvement and mapped pathways justify it.
  2. Dissect atraumatically. Preserve surrounding structures and sufficient vessel length. Avoid crushing, thermal injury, twisting or tension.
  3. Assess the actual vessels. Examine lumen, wall quality, lymph flow and venous reflux. A dermal-backflow pattern is not a one-to-one histologic classification of every collector.
  4. Choose the configuration for the vessels found. Favor a patent, tension-free connection with suitable outflow rather than a predetermined number of bypasses or a single configuration for every patient.
  5. Confirm flow before closure. Inspect lymph-to-vein flow under magnification, with fluorescence if appropriate. Document the site and configuration. Immediate flow does not establish long-term clinical benefit.
  6. Coordinate postoperative care. Protect the repair and agree when and how compression and drainage therapy resume. Published protocols differ; neither permanent compression cessation nor one universal restart day is established.

These principles are supported chiefly by limb operative reports and the ISL consensus; genital adaptations depend on the anatomy and associated procedure.[1][9][10][11][12]

Anastomotic configuration​

The names below describe the lymphatic first, vein second.

ConfigurationConsiderations
End-to-endJoins a lymphatic end to a venous end; useful when size and orientation permit.
End-to-sideJoins a lymphatic end to a venous side opening; can accommodate a recipient vein larger than the lymphatic.
Side-to-endJoins a lymphatic side opening to a venous end, preserving lymphatic continuity and potentially accepting flow from both directions. A small or poor-quality lymphatic wall can make the opening difficult.

Retrospective limb comparisons have reported better volume outcomes with side-to-end anastomoses in selected groups, but do not establish a universally superior genital configuration. The SEATTLE maneuver temporarily expands a collector to facilitate a side opening. Its original 48-patient limb study reported immediate technical patency in 42/44 versus 30/37 anastomoses, not a 95.5% patient cure rate; the suggested 0.35-mm threshold was that team's technical experience.[9][10][13]

Genital-specific applications​

Published approachWhat the evidence supports
Superficial genital and/or lower-limb LVASmall reports describe improvement in genital edema and lymphorrhea. Yamamoto's simultaneous genital/leg report included only two patients; it does not establish the optimal sites or number of bypasses.
Spermatic-cord lymphovenous derivationMukenge studied 11 men, of whom five underwent bypass from spermatic-cord collectors to pampiniform veins. This is a distinct, selected deep technique. Scrotal skin and testicular drainage are different systems; this report does not justify routine spermatic-cord dissection for superficial genital edema.
Genital acquired lymphangiectasiaLVA may be combined with vesicle resection in selected patients. Hara's 2018 series operated on 14 of 17 assessed patients; all 14 had LVA plus resection. Recurrence differed between preoperative drainage-pattern groups, so the comparison cannot be described as LVA versus no LVA. A later 25-woman series still reported recurrence in 10 patients.
MR-guided selectionLu's 36-man cohort included only three microsurgical patients. It supports feasibility of imaging-informed selection, not a general rule that a particular MR category mandates LVA or VLNT.

These reports are useful for technique selection and counseling, but cannot isolate the effect of LVA from concomitant treatment or establish comparative durability.[2][7][14][15][16][17]

Evidence that should guide counseling​

Randomized cellulitis evidence. A 2024 multicenter trial randomized 336 patients with secondary lower-limb lymphedema to LVA plus CDT or CDT alone. The primary full-analysis set included 225 after 111 patients with missing cellulitis data were excluded. At six months, the between-group difference in change in cellulitis frequency favored LVA by 0.35 episodes per six months (95% CI 0.09–0.62). Limb circumference and pain did not differ significantly. Interpretation is limited by substantial missing data, treatment crossover, lack of blinding and short follow-up. The analyzed cohort was almost entirely women after cancer treatment; this was not a trial of isolated genital lymphedema.[11]

Pooled limb outcomes are heterogeneous. Hahn's 2025 review included 52 studies and 1,920 treated extremities, mostly nonrandomized. It combined percentage changes in excess circumference or volume relative to the unaffected limb; these are not interchangeable with percentage reduction of the whole limb or genital volume. Heterogeneity was very high, and between-study LVA/VLNT comparisons cannot establish superiority. A separate long-term review reported fewer cellulitis episodes after either operation, again in limb cohorts.[4][18]

Benefit and patency are different endpoints. Patients may report less symptom burden or compression use without a significant circumference change. Conversely, a patent anastomosis is not proof of cure. Follow symptoms, infections, tissue measurements and ongoing treatment requirements alongside imaging when indicated.[4][19]

Costs remain setting-dependent. A 2026 economic analysis of a 100-woman breast-cancer RCT found that two-year cost-effectiveness estimates differed substantially between societal and healthcare perspectives, with uncertainty in incremental QALYs. These Dutch arm-lymphedema data do not establish genital-surgery cost-effectiveness or a universal financial benefit.[20]

Risks and follow-up​

Counsel about failure to improve, persistent or recurrent swelling, recurrent cellulitis, anastomotic occlusion, wound complications and the possible need for continued CDT or further surgery. If deeper genital dissection is proposed, discuss the structures at risk and alternatives. LVA avoids harvesting a lymph node flap, but is not risk-free. The frequently repeated 9% complication rate came from a small subset of a heterogeneous genital surgical review whose excisional groups tended to have later-stage disease; it should not be used to rank procedures or predict individual risk.[1][2][11][14]

Agree on scheduled wound and symptom review, reassessment of compression, and longer-term recording of swelling, lymphorrhea and infection episodes. Assess new or progressive edema for recurrent obstruction or another cause instead of presuming bypass failure. Promptly evaluate postoperative fever, spreading erythema, severe pain or wound breakdown.[1]

Prophylactic LVA​

Immediate lymphatic reconstruction during lymphadenectomy is a separate preventive strategy. Evidence largely concerns axillary surgery and arm lymphedema. It should not be presented as established prevention of genital lymphedema after pelvic lymph-node dissection, nor should it change the oncologically required operation without an appropriate multidisciplinary plan.[1][3]

See Also​

References​

1. Executive Committee of the International Society of Lymphology. The diagnosis and treatment of peripheral lymphedema: 2023 Consensus Document. Lymphology. 2023;56:133–151. Full consensus.

2. Guiotto M, Bramhall RJ, Campisi C, et al. A Systematic Review of Outcomes After Genital Lymphedema Surgery: Microsurgical Reconstruction Versus Excisional Procedures. Ann Plast Surg. 2019;83(6):e85-e91. doi:10.1097/SAP.0000000000001875

3. Chang DW, Dayan J, Greene AK, et al. Surgical Treatment of Lymphedema: A Systematic Review and Meta-Analysis of Controlled Trials. Results of a Consensus Conference. Plast Reconstr Surg. 2021;147(4):975-993. doi:10.1097/PRS.0000000000007783

4. Hahn BA, Kleeven A, Richir MC, et al. Objectifying Clinical Outcomes After Lymphaticovenous Anastomosis and Vascularized Lymph Node Transfer in the Treatment of Extremity Lymphedema: A Systematic Review and Meta-Analysis. Microsurgery. 2025;45(3):e70050. doi:10.1002/micr.70050

5. Hara H, Mihara M. Lymphatic ultrasound detects more vessels than indocyanine green lymphography in lymphedematous limbs. J Plast Reconstr Aesthet Surg. 2026;113:85-91. doi:10.1016/j.bjps.2025.11.005

6. Kadle RL, Chao AH. Imaging modalities in lymphatic surgery. Expert Rev Med Devices. 2025;22(10):1065-1071. doi:10.1080/17434440.2025.2554760

7. Lu Q, Jiang Z, Zhao Z, et al. Assessment of The Lymphatic System of the Genitalia Using Magnetic Resonance Lymphography Before and After Treatment of Male Genital Lymphedema. Medicine (Baltimore). 2016;95(21):e3755. doi:10.1097/MD.0000000000003755

8. Jang S, Lee CU, Hesley GK, et al. Lymphatic Mapping Using US Microbubbles before Lymphaticovenous Anastomosis Surgery for Lymphedema. Radiology. 2022;304(1):218-224. doi:10.1148/radiol.212351

9. Rodriguez JR, Yamamoto T. A Systematic Stepwise Method to Perform a Supermicrosurgical Lymphovenous Anastomosis. Ann Plast Surg. 2022;88(5):524-532. doi:10.1097/SAP.0000000000003023

10. Yamamoto T, Yoshimatsu H, Yamamoto N, et al. Side-to-end Lymphaticovenular anastomosis through temporary lymphatic expansion. PLoS One. 2013;8(3):e59523. doi:10.1371/journal.pone.0059523

11. Mihara M, Hara H, Kawasaki Y, et al. Lymphatic venous anastomosis and complex decongestive therapy for lymphoedema: randomized clinical trial. Br J Surg. 2024;111(1):znad372. doi:10.1093/bjs/znad372

12. Hara H, Mihara M, Seki Y, et al. Comparison of indocyanine green lymphographic findings with the conditions of collecting lymphatic vessels of limbs in patients with lymphedema. Plast Reconstr Surg. 2013;132(6):1612-1618. doi:10.1097/PRS.0b013e3182a97edc

13. Kwon JG, Jeong S, Pak CJ, et al. Comparative Analysis between Side-to-End and End-to-End Lymphaticovenous Anastomosis for Secondary Lower Limb Lymphedema. Plast Reconstr Surg. 2022;150(5):1138-1148. doi:10.1097/PRS.0000000000009647

14. Mukenge SM, Catena M, Negrini D, et al. Assessment and follow-up of patency after lymphovenous microsurgery for treatment of secondary lymphedema in external male genital organs. Eur Urol. 2011;60(5):1114-1119. doi:10.1016/j.eururo.2010.11.020

15. Yamamoto T, Koshima I, Yoshimatsu H, et al. Simultaneous multi-site lymphaticovenular anastomoses for primary lower extremity and genital lymphoedema complicated with severe lymphorrhea. J Plast Reconstr Aesthet Surg. 2011;64(6):812-815. doi:10.1016/j.bjps.2010.10.011

16. Hara H, Mihara M. Lymphaticovenous anastomosis and resection for genital acquired lymphangiectasia (GAL). J Plast Reconstr Aesthet Surg. 2018;71(11):1625-1630. doi:10.1016/j.bjps.2018.05.015

17. Hara H, Mihara M. Genital lymphaticovenous anastomosis (LVA) and leg LVA to prevent the recurrence of genital acquired lymphangiectasia. Microsurgery. 2021;41(5):412-420. doi:10.1002/micr.30733

18. Nicholas Jungbauer W, Solomon S, Verhey EM, et al. Lymphovenous Anastomosis and Vascularized Lymph Node Transfer Reduce Long-term Cellulitis Events in Patients With Secondary Lymphedema: A Systematic Review and Meta-analysis. Ann Plast Surg. 2025;95(5):522-530. doi:10.1097/SAP.0000000000004508

19. Wolfs JAGN, de Joode LGEH, van der Hulst RRWJ, et al. Correlation between patency and clinical improvement after lymphaticovenous anastomosis (LVA) in breast cancer-related lymphedema: 12-month follow-up. Breast Cancer Res Treat. 2020;179(1):131-138. doi:10.1007/s10549-019-05450-2

20. Kleeven A, Jonis YMJ, Currie O, et al. Economic evaluation of lymphaticovenous anastomosis versus conservative therapy for breast cancer-related lymphoedema: secondary outcome analysis of a randomized clinical trial. Br J Surg. 2026;113(6):znag062. doi:10.1093/bjs/znag062